JANEL OJEDA: Open Payments
NPI 1922510171 · LODI, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$601 in 30 payments from 10 companies in 2025. Trend: 2023 $795 · 2024 $462 · 2025 $601
Food & beverage: $601
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 7 | $144 |
| Abbott Laboratories | 5 | $120 |
| Novartis Pharmaceuticals Corporation | 3 | $61 |
| Exact Sciences Corporation | 3 | $58 |
| GlaxoSmithKline, LLC. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $47 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $41 |
| PFIZER INC. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
Products named: FREESTYLE LIBRE 3, MOUNJARO, LEQVIO, AREXVY, Kerendia, JARDIANCE, PREVNAR 20, ZEPBOUND.
Industry payments across CA — which companies pay providers there.
